These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27471866)

  • 1. Thrombotic microangiopathy during carfilzomib use: case series in Singapore.
    Chen Y; Ooi M; Lim SF; Lin A; Lee J; Nagarajan C; Phipps C; Lee YS; Grigoropoulos NF; Lao Z; Surendran S; Teh EM; Goh YT; Chng WJ; Gopalakrishnan SK
    Blood Cancer J; 2016 Jul; 6(7):e450. PubMed ID: 27471866
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
    Hobeika L; Self SE; Velez JC
    BMC Nephrol; 2014 Sep; 15():156. PubMed ID: 25267524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy after carfilzomib in a very young myeloma patient.
    Jeyaraman P; Borah P; Singh A; Chhabra GD; Khullar D; Dayal N; Naithani R
    Blood Cells Mol Dis; 2020 Mar; 81():102400. PubMed ID: 31887694
    [No Abstract]   [Full Text] [Related]  

  • 4. Carfilzomib: A cause of drug associated thrombotic microangiopathy.
    Qaqish I; Schlam IM; Chakkera HA; Fonseca R; Adamski J
    Transfus Apher Sci; 2016 Jun; 54(3):401-4. PubMed ID: 27017313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.
    Rassner M; Baur R; Wäsch R; Schiffer M; Schneider J; Mackensen A; Engelhardt M
    BMC Nephrol; 2021 Jan; 22(1):32. PubMed ID: 33461512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carfilzomib associated thrombotic microangiopathy initially treated with therapeutic plasma exchange.
    Sullivan MR; Danilov AV; Lansigan F; Dunbar NM
    J Clin Apher; 2015 Oct; 30(5):308-10. PubMed ID: 25413611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carfilzomib-induced Thrombotic Microangiopathy: A Case Based Review.
    Jindal N; Jandial A; Jain A; Lad D; Prakash G; Khadwal A; Nada R; Sethi J; Ahluwalia J; Malhotra P
    Hematol Oncol Stem Cell Ther; 2023 May; 16(4):426-431. PubMed ID: 32735793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement as the enabler of carfilzomib-induced thrombotic microangiopathy.
    Blasco M; Martínez-Roca A; Rodríguez-Lobato LG; Garcia-Herrera A; Rosiñol L; Castro P; Fernández S; Quintana LF; Cibeira MT; Bladé J; Fernández de Larrea C; Tovar N; Jimenez R; Poch E; Guillen E; Campistol JM; Carreras E; Diaz-Ricart M; Palomo M
    Br J Haematol; 2021 Apr; 193(1):181-187. PubMed ID: 32469083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, treatment, and outcomes of patients with carfilzomib induced thrombotic microangiopathy.
    Fang W; Sun W; Fang W; Zhao S; Wang C
    Int Immunopharmacol; 2024 Jun; 134():112178. PubMed ID: 38728883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carfilzomib-induced thrombotic microangiopathy. A case report.
    Scheggi V; Merilli I; Cesaroni E; Alterini B
    J Oncol Pharm Pract; 2022 Apr; 28(3):754-758. PubMed ID: 34904466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced Thrombotic Microangiopathy with Concurrent Proteasome Inhibitor Use in the Treatment of Multiple Myeloma: A Case Series and Review of the Literature.
    Monteith BE; Venner CP; Reece DE; Kew AK; Lalancette M; Garland JS; Shepherd LE; Pater JL; Hay AE
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e791-e800. PubMed ID: 32807717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly carfilzomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma: A phase 1 and PK/PD trial.
    Maruyama D; Tobinai K; Chou T; Taniwaki M; Shumiya Y; Iida S
    Cancer Sci; 2018 Oct; 109(10):3245-3252. PubMed ID: 30058108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carfilzomib-induced hemolysis is noticeably common but rarely shows features of thrombotic microangiopathy: A retrospective study.
    Kozlowski P; Kameran Behnam K; Uggla B; Åström M
    Eur J Haematol; 2020 Jun; 104(6):588-593. PubMed ID: 32115785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review.
    Terao T; Tsushima T; Miura D; Ikeda D; Fukumoto A; Kuzume A; Tabata R; Narita K; Takeuchi M; Matsue K
    Leuk Lymphoma; 2022 May; 63(5):1102-1110. PubMed ID: 35373680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab.
    Bhutani D; Assal A; Mapara MY; Prinzing S; Lentzsch S
    Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):e155-e157. PubMed ID: 32098724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proteinuria in multiple myeloma: Be careful to iatrogeny].
    Sapet M; Fouillet L; Daguenet E; Laurent B; Guyotat D; Le Jeune C
    Bull Cancer; 2020 Apr; 107(4):519-520. PubMed ID: 32178835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Not Available].
    Attucci I; Pilerci S; Messeri M; Pengue L; Tomasino G; Caroti L; Vannucchi AM; Antonioli E
    Cancer Rep (Hoboken); 2024 Oct; 7(10):e2163. PubMed ID: 39390755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA.
    Ponraj R; Bryant A; Dunlop L; Range H; Cobrador C; Ling S; Hsu D
    Blood Cancer J; 2023 Jul; 13(1):113. PubMed ID: 37495597
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma.
    Chan KL; Filshie R; Nandurkar H; Quach H
    Leuk Lymphoma; 2015 Jul; 56(7):2185-6. PubMed ID: 25547654
    [No Abstract]   [Full Text] [Related]  

  • 20. Ixazomib-induced thrombotic microangiopathy.
    Yui JC; Dispenzieri A; Leung N
    Am J Hematol; 2017 Apr; 92(4):E53-E55. PubMed ID: 28133842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.